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Abstract

Thrombelastography Parameters versus Classical Coagulation Profile in Trauma Patients:
a Retrospective Study
by
Abdulraouf Y. Lamoshi
Master in Clinical and Translational Sciences in
West Virginia University
Alison Wilson, MD, FACS, Chair
The West Virginia University Guide to the Preparation of Masters Theses Abdulraouf Y.
Lamoshi Thrombelastography Parameters versus Classical Coagulation Profile in Trauma
Patients: a Retrospective Study Background: Thrombelastography (TEGTM, Hemoscope,
Niles, IL) is increasingly utilized. As TEG depicts overall coagulation it may be more comprehensive and capable to detect any coagulation abnormalities in comparison to classical
coagulation tests (CCT: PT, PTT, INR, platelets). Traumatic brain injury (TBI) is thought
to contribute to coagulopathy. The primary aim was to compare TEG parameters of TBI vs.
Non-TBI patients. The secondary aim was to identify TEG vs. CCT parameters associated
with outcome (mortality, need for transfusion, length of stay).
Methods: This is a cross sectional retrospective observational study of 142 patients (full
trauma team activations only) admitted to a university based, Level 1 trauma center. TEG
and CCT were collected on admission. Citrated Kaolin samples were utilized. Data was
analyzed by a biostatistician using JMP V10.
Results: 142 patients (pts), 44 (31%) women and 98 (69%) men. 48 pts had TBI and 94
pts were NTBI. Overall mortality was 20.4% (45.8% TBI vs. 7.4% NTBI). There were no
significant associations between TEG or CCT parameters and ISS, scene vs. transfer, hospital LOS, or ventilator days. There was no difference between the TBI and NTBI groups in
terms of TEG or CCT parameters. Variables found to be associated with mortality were K
(p = 0.0118) and age (p = 0.0057). MA was the only parameter (TEG or CCT) associated
with need for transfusion of PRBC (p= 0.0377). PRBC transfusion was given in 94% of 16
patients with an M A ≤ 57.4 (1-4 units in 44% and ≥ 4 units in 50%). Platelet transfusion
was given in 89% of 9 patients who have M A ≤ 58.1. FFP transfusion was given in 80%
of 15 patients who have R ≥5.8. Decreased MA (p = 0.0003), ↓ K (p = 0.0154), ↑ PT
(p = 0.0015), and ↑ INR (p = 0.0014) are significantly associated with FFP transfusion. K
value is significantly associated with mortality (p = 0.0118) and hypotension (p = 0.0172).
Conclusions: TEG parameters are potentially useful as means to rapidly diagnose coagulopathy and predict transfusion in trauma pts. Independently, presence of TBI does not cause a
detectable coagulopathy. MA is best single indicator for PRBC and/or FFP transfusion in
trauma patients. TEG analysis is more efficient than the classical parameters in detecting
patients who will need PRBC and FFP transfusion.
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Chapter 1
Background
Blood transfusion protocols are crucial measures in all trauma settings and many other
medical situations. Choosing the appropriate timing and type of blood and/or blood product transfusions are sometimes vital decisions that determine the future of trauma patients
[1] Head injury forms approximately 45% of trauma-related mortalities and bleeding is the
second most common cause of death, 30%, during the early stages of trauma[2] On the
other hand, multiorgan failure leads to 8% of deaths in the late trauma incidents, which is
associated with massive transfusion that can lead to coagulopathy in 65% of the cases and
increase the risk of death by 50%[2]. Thus, constructing a scientifically founded strategy to
predict the precise need for transfusion to face the different scenarios can save a lot of morbidities and fatalities. In 1948 Hartert invented the Thromboelastograph (TEG) technique
to quantify the dynamics of clot development and termination throughout its progression
stages where it evaluates the interaction between fibrinogen, platelets, and clotting factors.3
In comparison, the classical laboratory screening tests of coagulation, which include fibrinogen level, thrombin clotting times (TCT or thrombin time, TT), the PT, and the APTT,
measure only the progression of the clotting cascade until the time of first fibrin development (Figure 1.1).3 Moreover, aPTT and INR neglect the platelets effect because the tests
are executed on platelet-poor plasma samples and CCT results may take up to 30 minutes
to be available which means precious time for intervention is lost 4.5. The main TEG parameters are R-time (or reaction time), K-time (or clot formation time), angle of alpha (α)
(function of rate of fibrin polymerization) and MA (Maximum Amplitude) (Figure 1.2).3
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R is increased due to anticoagulants, factor deficiencies, and severe hypofibrinogenaemia

Figure 1.1: An overview of the cell-based model of coagulation. Curry, Andy NG, and JM
Tom Pierce. ”Conventional and near-patient tests of coagulation.” Continuing Education in
Anaesthesia, Critical Care & Pain 7, no. 2 (2007): 45-50.
and decreased by hypercoagulable conditions.3,6 K is increased due to anticoagulants, hypofibrinogenaemia, thrombocytopenia and declined by increased fibrinogen level, increased
platelet function.3.6 α is prolonged by increased fibrinogen level, increased platelet function and shortened by anticoagulants, hypofibrinogenaemia, thrombocytopenia.3,6 MA is
prolonged by hypercoagulable states, thrombocytosis and shortened by thrombocytopenia,
platelet blockers, fibrinolysis, factor deficiencies.3,6
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Figure 1.2:
:
Graphical Representation of TEG Parameters.
Ereth, Mark.
Blood CME Center, ”Uncontrolled Bleeding After Thoracic Aortic Aneurysm Repair: A Case Report and Interactive Discussion.” Last modified 2013.
Accessed
June 10, 2013. http://www.bloodcmecenter.org/BeginActivity.aspx?AID=49 & ST=1 &
pg=ClinicalBrief1/Intro.
Severely injured patients may need large amounts of blood and blood products; however,
there is no accurate blood tests that can predict the optimum time, type, and amount that
patients really need[3] Depending primarily on the classical coagulation lab tests has many
limitations that may lead to deadly outcomes[3] Post-traumatic patients, who are in hypovolemia shock, may need massive transfusion which causes dilution of coagulation factors
and platelets that in turn leads to coagulopathy disorders 7 including venothromboembolic
consequences[4]. TEG has been used to predict the demand for blood transfusion in surgeries
that have high likelihood of bleeding settings such as orthotopic surgeries, liver transplantation and cardiopulmonary bypass, and in the field of trauma where it showed precise
prediction for transfusion in the first day[4]. Nonetheless, TEG has not been used to measure the severity of coagulability based on different types of trauma, for example, traumatic
brain injury[4]. According to previous studies, coagulopathy is more likely to develop in brain
traumatic injuries patients and correlates to their high death rates[5][6]. Although the exact
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correlation between TBI and DIC is not fully explained, as a consequence to TBI, vascular
or tissue injury releases a brain rich tissue factor (thromboplastin), which stimulates other
extrinsic pathway procoagulant proteins that traps platelets and activates further thrombosis including DIC[6][7][8]. Moreover, TBI inhibits α 2-plasmin inhibitor activity which leads
to major fibrinogenolysis[6].
The primary goal of this retrospective observational study was to compare TEG parameters
of TBI vs. NTBI patients. The secondary aim was to identify TEG vs. CCT parameters
association with the studied outcomes, including prediction of transfusion needs in trauma.

5

Chapter 2
Methods and Results
2.1

Methods

This is a cross-sectional retrospective observational study of 142 patients (full trauma
team activations only) admitted to a university based, Level 1 trauma center. TEG and
CCT (INR, aPTT, TT, fibrinogen, platelet count) were collected on admission. Citrated
Kaolin samples were utilized. TEG machines are subjected to electronic controls three times
daily and liquid controls once a day. In addition to TEG and CCT values the following
variables were collected: gender, age, scene versus transferred patients, ISS, AIS, Craniotomy/ectomy, type of brain injury, discharge status (alive versus dead), BP, blood and
blood product transfusion, hospital length of stay, and ventilator days. The relationship between TEG and CCT parameters were analyzed using all these variables. TEG samples were
sent from the trauma-bay within 15 minutes of arrival to the hospital. TBI cases diagnosed
based on Glascow Coma Scale and CT scan which showed intracranial injury.
Statistical analysis was performed using SAS, version 10 (SAS Institute Inc, Cary, North
Carolina). Categorical data were analyzed using Chi-square or Fisher exact test. A comparison of continuous variables between TBI and NTBI patients was performed using the
independent-sample t test. Comparisons among the two groups were performed by one-way
ANOVA followed by the Tukey correction for post-hoc comparisons. Wilcoxon / KruskalWallis Tests were used when appropriate. Pearson correlation coefficients were calculated
between continuous variables. P values of.05 or less than were considered statistically sig-
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nificant and data are reported as mean (SEM).

2.2

Results

Out of 142 patients, there were 44 (31%) women and 98 (69%) men. Forty-eight patients
had a TBI and 94 pts were NTBI. Overall mortality was 20.4% (45.8% TBI vs 7.4% NTBI).
Of the 48 TBI patients, 7 (15%) were diagnosed with IVH, 22 (46%) IPH/CC, [2] (4%)
EDH, 31 (64%) SDH, and 26 (54%) SAH. The patients with systolic blood pressure above
90 had a greater hospital length of stay (6.9 days vs. 14.7 days) (P = .0001). Also SBP
≥ 90 significantly associated with ISS where those patients who had low ISS (average of
13) had also SBP ≥ 90 and those who had high ISS (average of 19) had also SBP ≤ 90
(P = 003). There were no significant associations between TEG or CCT parameters and
ISS, scene vs. transfer, hospital LOS, or ventilator days (Table 1). There was no difference
between the TBI and NTBI groups in terms of TEG or CCT parameters (Table 2). The
number of patients who were sent from the scene directly to our facility was 89 out of which
15 (17%) died during the admission. Comparably, 53 patients were transferred from other
facilities out of which 14 (26%) died showing no significant difference in overall mortality
(P = .171). This matched the severity of injuries where 38% of the scene group had ISS
greater than 15 compared with 34% of the transferred group (P = .611).Variables found to
be associated with mortality were K (p = 0.0118) and age (p = 0.0057).
MA was the only parameter (TEG or CCT) associated with the need for transfusion of
PRBC (p = 0.0377). PRBC transfusion was given in 94% of 16 patients with MA ≤ 57.4
(1-4 units in 44% and ≥ 4 units in 50%) and only in 53% of 63 patients with MA ≥ 57.4
(Figure 2.1). MA also significantly associated with FFP transfusion (Figure 2.2).Platelet
transfusion was given to 89% of 9 patients who have MA ≤ 58.1 and only in 44% of 55
patients with MA ≥58.1.
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Table.1: P Value of Associations of all TEG and CCT Parameters with the Studied
Variables

Variable
Gender
Age
Length of stay
Ventilation days
Scene vs. transfer
Mortality
ISS ≤ 15
ISS
SBP≥ 90
Hypotension
Coumadin
PRBC
FFP
Platelets
Craniotomy

R
0.398
0.343
0.297
0.811
0.868
0.976
0.137
0.476
0.443
0.63
0.64
0.31
0.201
0.507
0.768

K
0.147
0.895
0.736
0.788
0.971
0.012
0.562
0.138
0.196
0.017
0.628
0.284
0.015
0.134
0.805

MA
0.106
0.148
0.830
0.901
0.086
0.417
0.078
0.254
0.168
0.335
0.383
0.038
0.000
0.138
0.65

Angle INR

PT

0.39 0.779
0.207 0.192
0.733 0.414
0.147
0.832
0.857 0.141
0.69
0.113
0.095
0.352
0.261

0.002
0.7
0.663
0.001 0.002
0.502 0.494

Table.2: CCT and TEG Parameters of TBI vs. NTBI Patients

Parameter
R
K
MA
Angle
INR
PT

TBI (X + SE)
9.21 ± 2.73
2.11± 0.25
63.00± 1.15
67.11± 1,33
1.25± 0.14
12.77± 0.55

NTBI (X+ SE)
5.38±1.72
1.63± 1.6
63.04± 0.72
67.68± 0.9
1.38± 0.11
12.68± 0.42

P value
0.237
0.111
0.977
0.726
0.518
0.91
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MA and PRBC
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Figure 2.1: Correlation of MA Cut-off Point with PRBC Transfusion

MA and Platelets
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MA < 58.1
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Figure 2.2: Correlation of MA Cut-off Point with Platelets Transfusion
Additionally, FFP transfusion was given to 80% of 15 patients who have R ≥ 5.8 and
only in 32% of 50 patients with R ≤ 5.8 (Figure 2.3). with α ≥ 62.9. Platelet transfusion
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was given to 70% of 14 patients who have α ≤ 64.5 and only in 44% of 50 patients with α ≥
64.5. FFP transfusion was given to 67% of 25 patients who have α ≤ 66.3 and only in 28%
of 40 patients with α ≥ 66.3 (Figure 2.4). K value is significantly associated with mortality
R and FFP
90

80

% of Patients

70

60

50

40

FFP

30

20

10

0

R ≥ 58

R < 58

R Cut-off point

Figure 2.3: Correlation of R Cut-off Point with FFP Transfusion

Alpha and FFP
80%

70%

60%

Patients

50%

40%

FFP Transfusion
30%

20%

10%

0%

α < 66.3

α ≥ 66.3

Alpha Cut-off Point

Figure 2.4: Correlation of Alpha Cut-off Point with FFP Transfusion
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(p = 0.0118), hypotension (p = 0.0172), and FFP transfusion (p = 0.0154) (Figures 2.5, 2.6,
2.7).

Figure 2.5: Correlation of K Measurement with Blood Pressure Status

Figure 2.6: Correlation of K Measurement with Mortality Rate
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Figure 2.7: Correlation of K Measurement with FFP Transfusion
Decreased MA (p=0.0003), decreased K (p=0.0154), increased PT (p= 0.0015), and
increased INR (p=0.0014) were significantly associated with FFP transfusion.

12

Chapter 3
Discussion
This study concludes that TEG parameters are a potentially useful means to rapidly
diagnose coagulopathy and predict transfusion in trauma pts. Independently, presence of
TBI does not cause a detectable coagulopathy on admission. MA is best single indicator for PRBC and/or FFP transfusion in trauma patients. TEG analysis is more efficient
than the classical parameters in detecting patients who will need PRBC and FFP transfusion. Although, blood transfusion is a vital decision that can save patients lives especially
in emergency and operating settings, there is no a quick and trustworthy test to assess in
vivo the coagulation statuses of those patients[9].Early transfusion of plasma and PRBC
is a recommended step in the most massively bleeding and critically injured patients[10].
Nonetheless, a new study suggested that transfusing 6 platelet units for each 78 units of
PRBC can improve the survival rates in massive transfusion patients[10]. Furthermore, giving extra cryoprecipitate units is not known to raise fibrinogen and von Willebrands factor or
carry any benefits[10].TEG can provide a foundation to develop a transfusion protocol that
uses patients’ hemostatic statuses[9]. This study reported that when MA is less that 58.1
mm, the majority of the patients need PRBC and/or FFP. MA represents the maximum
clot strength and relates to the quality of fibrin and platelet interaction which depends on
platelet number and/or function[11]. This explains the precision and ability of MA and the
failure of CCT parameters, including platelets number, to interpret such needs. Even though
some changes in other parameters, K, PT, and INR, correlated with FFP transfusion that
did not show a specific cut-off point nor any association with PRBC transfusion. K-time
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(clot formation time) represents the level of clot firmness and clot formation kinetics[11].
Our study reported that low K is significantly associated with hypotension and high mortality rates (lower among those who are alive and have no hypotension). This is due to
the fact that patients who are hypotensive are more prone to develop bleeding disorders and
increased death rates[7]. Additionally, the majority of our patients sample did not need FFP
transfusion until their R values reached [3][4]. This reflects the ability of R to exclude those
patients who have the least likelihood to need FFP. Furthermore, α Angle value of ≤ 62.9
was able to predict the need of the preponderance (77%) of the sample for transfusion. This
finding has been found by other study that showed when α Angle parameter was utilized it
predicted 84% of the patients need for transfusion[12]. The results are supported by previous
similar studies that showed that TEG is a valuable technique to monitor the coagulation
status of TBI patients. It can differentiate between the various causes of coagulopathy, and
can provide appropriate guidance for blood, blood products and other intervention[9][13][14].
Moreover, Maegeles study revealed that TBI patients who develop coagulopathy have about
10 times higher chance of death than those patients who do not suffer from coagulopathy[8].
Additionally, Plotkins et al. study stated that PT and PTT are unable to determine which
step of the clotting flow is affected in coagulopathic patients[9]. However, employing TEG
can provide a more precise diagnosis of clotting dysfunctional disorders[9]. The CCT (INR
and PT) showed only a significant association with the need for FFP transfusion, which has
been also predicted by TEG parameters, MA and K. Furthermore, CCT did not show any
advantage over TEG parameters on the rest of the studied variables, including the need for
blood and other blood products transfusion, hypotension or the mortality rate. This can
be explained by the limited abilities of CCT to detect the other hemostatic abnormalities
that participate in bleeding tendency such as the efficiency of the platelets to develop stable
clot when their numbers are within the normal range. We report that there is no difference
between TBI and NTBI groups in terms of coagulation status that has been found by another study that stated that in order to develop TBI early coagulopathy, TBI patients should
have a tissue injury and tissue hypoperfusion[5][7]. Additionally, according to Talvings et al.
study, the published rates of coagulopathy in brain traumatic patients is not in agreement
and shows very wide ranges (8%-86%).9 Furthermore, Genets et al. study concluded that
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there were no significant biomarker differences between TBI and non-TBI patients, and the
coagulopathy status does not depend on the site of injury but rather on its severity[15].
In trauma settings, the main goal of damage control resuscitation (DCR) is to avoid the
progress of the lethal triad of coagulopathy, metabolic acidosis, and hypothermia or to reduce the required time for the appropriate intervention once the triad begins to evolve[16].
Tailored intervention to treat coagulopathy has not been well defined; it has been considered
only as a result of resuscitation, hemodilution, and hypothermia, and partially attributed to
blood banking procedures delay[17]. DCR intraoperatively by blood products has showed a
decent improvement in survival by adopting a rapid correction of trauma-induced coagulopathy in military and civilian injured patients[18]. Based on the fact that early development
of coagulopathy in trauma patients, aggressive fluid replacement may lead to reperfusion
injury, and massive transfusions are correlated with a high mortality rate, the most seriously
injured patients may benefit from a resuscitation approach depends on the accurate timing
and assessment of their coagulation statuses[19]. The current practice in patients who need
massive transfusion is to give fresh frozen plasma, packed red blood cells, and platelets in
a 1:1:1 ratio[20]. This approach is theoretically eye-catching; however, it has been built
on only two retrospective observational studies that revealed improvement in the survival
rate with this regimen. Thus, more rigorous studies are demanded before firm guidelines
are recommended particularly in the civilian settings[20]. Based on the current and previous work that evaluated TEG effectiveness to assess the coagulation status, this study
proposes using TEG to assess the coagulation statuses of the trauma patients and predict
their accurate needs for transfusions[12][4][13]. This study has a number of strengths. First,
this study was analyzed over more participants (142) as compared to other studies such as
Park et al.[4] (78), Plotkin et al.[9] (44), and Cohen et al.[7] (39). Second, this is the first
study to our knowledge comparing TBI with NTBI in terms of TEG and CCT parameters.
Third, sending the TEG sample from the trauma-bay, within 15 minutes after arrival, leads
to highly reliable results. This is because the samples are taken before any blood or blood
products transfusion. This matches the recommended guidelines for standard coagulation
measures[4]. There were a number of constraints in the study. First, it was a retrospective
and a single center study. Second, some classical coagulation test results are missing. Third,
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transferred patients from the other facilities could spend a long time before they get TEG
samples drawn and/or received blood or blood products; however all of them came through
the ED as a trauma activation, thus they still have the same timeline. Fourth, fibrinogen,
which is one of the most sensitive CCT, was not collected for the majority of the patients;
however, numerous trauma centers do not depend on this test, since results are commonly
not available for several hours[12]. Future research should be prospective where more than
one TEG test can be run on each patient, complications can be recorded, and be compared
to the results of the tests (TEG or CCT) which can predict the clinical correlation. Multicentric study can eliminate any subjective bias, use the same protocol in all facilities, and
avoid the above stated limitations. Also, we suggest further investigation of TEGs cut-off
points that showed significant results in this study.
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